Evidence map›Paper›PMID 32210820›Full record

ArticleFrontiers in pharmacology2020

Fumitremorgin C Attenuates Osteoclast Formation and Function

Yu Yuan, Kai Chen, Xi Chen, Chao Wang, Heng Qiu, Zhen Cao, Dezhi Song, Youqiang Sun, Jianmin Guo, Jennifer Tickner and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Yu YuanSchool of Kinesiology, Shanghai University of Sport, Shanghai, China.
Kai ChenSchool of Biomedical Sciences, University of Western Australia, Perth, WA, Australia.
Xi ChenSchool of Sports Science, Wenzhou Medical University, Wenzhou, China.
Chao WangSchool of Biomedical Sciences, University of Western Australia, Perth, WA, Australia.
Heng QiuSchool of Biomedical Sciences, University of Western Australia, Perth, WA, Australia.
Zhen CaoSchool of Biomedical Sciences, University of Western Australia, Perth, WA, Australia.
Dezhi SongSchool of Biomedical Sciences, University of Western Australia, Perth, WA, Australia.
Youqiang SunDepartment of Orthopedics, First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, China.
Jianmin GuoSchool of Kinesiology, Shanghai University of Sport, Shanghai, China.
Jennifer TicknerSchool of Biomedical Sciences, University of Western Australia, Perth, WA, Australia.
Jiake XuSchool of Biomedical Sciences, University of Western Australia, Perth, WA, Australia.
Jun ZouSchool of Kinesiology, Shanghai University of Sport, Shanghai, China.
University of Western Australia · AUShanghai University of Sport · CNWenzhou Medical University · CNFirst Affiliated Hospital of Guangzhou University of Chinese Medicine · CNSouth China Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Excessive bone resorption conducted by osteoclasts is considered as the main cause of osteoclast-related bone diseases such as osteoporosis. Therefore, the suppression of excessive osteoclast formation and function is one of the strategies to treat osteoclast-related bone diseases. Fumitremorgin C (Fum) is a mycotoxin extracted from

Indexed as

fumitremorgin CMAPKNFATc1osteoclastosteoporosis

Identifiers

PMID32210820
PMCPMC7076231
OpenAlexW3010827912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.